Cargando…
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers
BACKGROUND: Monitoring is essential to ensure patient safety and data integrity in clinical trials as per Good Clinical Practice. The Standard Protocol Items: Recommendations for Interventional Trials Statement and its checklist guides authors to include monitoring in their protocols. We investigate...
Autores principales: | Hsieh, Shao-Fan, Yorke-Edwards, Victoria, Murray, Macey L, Diaz-Montana, Carlos, Love, Sharon B, Sydes, Matthew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021127/ https://www.ncbi.nlm.nih.gov/pubmed/36629015 http://dx.doi.org/10.1177/17407745221143449 |
Ejemplares similares
-
Making a distinction between data cleaning and central monitoring in clinical trials
por: Love, Sharon B, et al.
Publicado: (2021) -
Monitoring in practice – How are UK academic clinical trials monitored? A survey
por: Love, Sharon B., et al.
Publicado: (2020) -
Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data
por: Love, Sharon B., et al.
Publicado: (2021) -
Early warnings and repayment plans: novel trial management methods for monitoring and managing data return rates in a multi-centre phase III randomised controlled trial with paper Case Report Forms
por: Cragg, William J., et al.
Publicado: (2019) -
Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
por: Lensen, Sarah, et al.
Publicado: (2020)